COVALENT-101: phase I study of BMF-219, a covalent menin inhibitor, in adult patients with AML, ALL (with KMT2A/ MLL1r, NPM1 mutations), DLBCL, MM, and CLL/SLL (NCT05153330)Aaron Rosenberg,Muhamed Baljevic,Adrian Alegre Amor,Jacqueline Barrientos,Asad Bashey,Rachid Baz, Juan Bergua Burgues,Sosana Delimpasi,Efstathios Kastritis,Tahir Latif,Lisa Lee,Maria-Victoria Mateos,Daniel Morillo,Pau Montesinos,Ricardo Parrondo,Gary Schiller,Emily Curran,Ashwin Kishtagari,Thomas Butler,Alex Cacovean, Courtney Follit, Clarissa Mandap,Steve Morris,Jack KhouriCLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）引用 0|浏览21暂无评分关键词covalent-101 menin inhibitor,npm1 mutations,amlAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
